Brimonidine Tartrate CAS 70359-46-5 Assay 99.0% ~ 101.0%
Shanghai Ruifu Chemical Co., Ltd. shine babban kamfani na Brimonidine Tartrate (CAS: 70359-46-5) tare da inganci.Zaɓaɓɓen α2-adrenergic agonist mai karɓa, magani da ake amfani da shi don magance glaucoma mai buɗe ido ko hauhawar jini na ido.Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi Brimonidine Tartrate,Please contact: alvin@ruifuchem.com
| Sunan Sinadari | Brimonidine Tartrate |
| Makamantu | Brimonidine L-Tartrate;Birtaniya 14304 Tartrate;AGN190342 Tartrate;5-Bromo-N- (4,5-Dihydro-1H-Imidazol-2-yl) quinoxalin-6-Amine Tartrate;5-Bromo-N- (4,5-Dihydro-1H-Imidazol-2-yl) -6-Quinoxalinamine Tartrate;5-Bromo-N-(4,5-Dihydro-1H-Imidazol-2-yl)quinoxalin-6-Amine (2R,3R) -2,3-Dihydroxysuccinate |
| Matsayin Hannun jari | A Stock, Kasuwancin Kasuwanci |
| Lambar CAS | 70359-46-5 |
| Tsarin kwayoyin halitta | C11H10BrN5·C4H6O6 |
| Nauyin Kwayoyin Halitta | 442.23 g/mol |
| Matsayin narkewa | 207.0 ~ 208.0 ℃ |
| M | Hankalin iska, Mai jin zafi |
| COA & MSDS | Akwai |
| Asalin | Shanghai, China |
| Rayuwar Rayuwa | Watanni 24 Idan An Ajiyesu Da Kyau |
| Kashi | API (Magungunan Magunguna masu Aiki) |
| Alamar | Ruifu Chemical |
| Abubuwa | Ƙayyadaddun bayanai | Sakamako |
| Bayyanar | Fari ko Dan Jawo-wasa ko Foda mai launin ruwan kasa kaɗan | Ya dace |
| Identification A | Takamaiman Juyawar gani | Ya dace |
| Identity B | Infrared Absorption Spectrophotometry | Ya dace |
| Solubility | Mai narkewa a cikin ruwa, kusan ba zai iya narkewa a cikin ethanol mai anhydrous da kuma cikin toluene | Ya dace |
| Takamaiman Juyawar gani | +9.0° ~ +10.5° | +9.6° |
| Asara akan bushewa | ≤0.50% | 0.20% |
| Sulfated ash | ≤0.20% | 0.07% |
| Karfe masu nauyi | ≤20ppm | <20ppm |
| Abubuwa masu alaƙa | ||
| ƙayyadaddun ƙazanta | ||
| N-(imidazolidin2ylidene)quinoxalin-6-amin | ≤0.10% | Ya dace |
| 5-bromoqulinoxalin-6-amin | ≤0.10% | Ya dace |
| Quinoxalin-6-amin | ≤0.10% | Ya dace |
| 1- (5-bromoquinoxalin-6-yl) thiourea | ≤0.10% | Ya dace |
| 2- (5-bromoquinoxalin-6-yl) guanidine | ≤0.10% | Ya dace |
| 5-bromo-N-(1H-imidazol-2-yl)Quinoxalin-6-amine | ≤0.10% | Ya dace |
| 1- (2-aminoethyl) -3- (5-bromoquinoxalin-6-yl) urea | ≤0.10% | Ya dace |
| Abubuwan da ba a bayyana ba | ≤0.10% | Ya dace |
| Jimlar | ≤0.20% | 0.12% |
| Assay | 99.0% ~ 101.0% (a kan Busassun Tushen) | 99.8% |
| Kammalawa | Wannan samfurin ta hanyar dubawa ya dace da ma'aunin BP2015 | |
Kunshin:Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye akwati sosai kuma a adana a wuri mai sanyi, bushe (2 ~ 8 ℃) da ma'ajin da ke da isasshen iska daga abubuwan da ba su dace ba.Ka guji fallasa zuwa hasken rana kai tsaye, danshi da zafi mai yawa.
Jirgin ruwa:Isar da shi zuwa duniya ta iska, ta FedEx / DHL Express.Bayar da isarwa cikin sauri kuma abin dogaro.
Yadda ake siya?Da fatan za a tuntuɓiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Kwarewar Shekaru 15?Muna da fiye da shekaru 15 na gwaninta a cikin ƙira da fitarwa na matsakaicin matsakaicin magunguna masu inganci ko sinadarai masu kyau.
Manyan Kasuwanni?Sayarwa zuwa kasuwannin cikin gida, Arewacin Amurka, Turai, Indiya, Koriya, Jafananci, Australia, da sauransu.
Fa'idodi?Babban inganci, farashi mai araha, sabis na ƙwararru da tallafin fasaha, bayarwa da sauri.
inganciTabbaci?Tsananin kula da ingancin inganci.Kayan aikin ƙwararru don bincike sun haɗa da NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, gwajin ƙayyadaddun ƙwayoyin cuta, da sauransu.
Misali?Yawancin samfurori suna ba da samfurori kyauta don ƙima mai kyau, farashin jigilar kaya ya kamata a biya ta abokan ciniki.
Binciken Masana'antu?Ma'aikata duba maraba.Da fatan za a yi alƙawari a gaba.
MOQ?Babu MOQ.Karamin tsari abin karɓa ne.
Lokacin Bayarwa? Idan cikin hannun jari, garantin isar da kwana uku.
Sufuri?By Express (FedEx, DHL), ta Air, ta Teku.
Takardu?Bayan sabis na tallace-tallace: COA, MOA, ROS, MSDS, da dai sauransu za a iya ba da su.
Haɗin Kan Al'ada?Zai iya ba da sabis na haɗawa na al'ada don dacewa da buƙatun bincikenku.
Sharuɗɗan Biyan kuɗi?Za a fara aiko da daftari na Proforma bayan tabbatar da oda, an rufe bayanan bankin mu.Biya ta T/T (Telex Transfer), PayPal, Western Union, da dai sauransu.
Bayanin Hazard H301: Mai guba idan an hadiye shi.
Kalaman Rigakafi
P501: Zuba abun ciki/kwantena zuwa wurin da aka amince da sharar sharar gida.
P270: Kada ku ci, sha ko shan taba lokacin amfani da wannan samfurin.
P264: A wanke fata sosai bayan sarrafa.
P301 + P310 + P330: IDAN AN HADUWA: Nan da nan kira cibiyar guba/likita.Kurkura baki.
P405: Store a kulle.
Dokokin masu alaƙa:
Bayanan sufuri:
Lambar UN (DOT-AIR) UN2811
Class (DOT-AIR) 6.1
Rukunin tattarawa (TCI-A) III
Lambar HS 2933.29.9000
Brimonidine Tartrate (CAS: 70359-46-5) babban zaɓi ne na α2-receptor blocker, wanda Kamfanin Allergan na Amurka ya sami nasarar haɓaka shi, wanda shine maganin ido.Yana iya rage matsa lamba na intraocular (IOP).Brimonidine Tartrate ophthalmic maganin saling a kasuwa shine nau'in Brimonidine Tartrate, wanda shine kyakkyawan magani na rage IOP don cutar hawan jini na glaucoma na yau da kullun da jiyya na hauhawar jini na marasa lafiya, amma kuma don matakan IOP na laser argon.Maganin ido na Brimonidine Tartrate yana da tsarin aiki guda biyu ta hanyar rage samar da jin daɗin ruwa da haɓaka launi mai launi na dalilai na warkewa na scleral.Bayan faduwa a cikin ido, tasirin yana da sauri, kuma zai iya kaiwa ga kololuwar lokacin amfani da har zuwa 2h, kuma lokaci mai tasiri zai iya kula da 12h.Jini zai iya gano alamun magunguna kawai.Wannan samfurin yana da metabolism na farko a cikin hanta, da kuma metabolites da ke fitar da fitsari ta hanyar kodan.Ba a shafa tsarin sha da rarrabawa ba, kuma tsofaffi ba sa buƙatar daidaitawar kashi.Brimonidine Tartrate maganin ophthalmic bayani idan aka kwatanta da sauran α-blockers, mai-mai narkewa yana da ƙananan, yayin da ba shi da sauƙi don wucewa ta hanyar shinge na kwakwalwa na jini kuma baya haifar da tashin hankali, hypotension da sauran irin halayen tsakiya na clonidine.Brimonidine Tartrate Ophthalmic Magani yana da zaɓi sosai don masu karɓa na α2-adrenergic, kuma α2 / α1 rabo na haɗin mai karɓa ya fi sau 1000.Tasirin masu karɓar alpha 2 na iya haifar da ƙananan matsa lamba na intraocular.Kuma rawar masu karɓar alpha 1 na iya haifar da rikicewar jijiyoyin jini, ja da baya ko ragewa da faɗaɗa ɗalibin.Yin aiki na dogon lokaci na wannan samfurin ba zai haifar da rashin jin daɗi cikin sauri ba.Bugu da ƙari, idan aka kwatanta da β-blockers, Brimonidine Tartrate ido ya sauke don ƙananan cututtuka na zuciya, ba shi da tasiri a kan aikin huhu, don haka ya dace da marasa lafiya β-blockers.Bugu da ƙari, lokacin amfani da β-blocker kadai, ba zai iya cimma dalilai na warkewa ba, kuma kuna iya ƙara FDA lokaci guda.
